Laquinimod reduces neuroaxonal injury through inhibiting microglial activation.
about
Laquinimod in the treatment of multiple sclerosis: a review of the data so farRemyelination Therapy in Multiple SclerosisLaquinimod rescues striatal, cortical and white matter pathology and results in modest behavioural improvements in the YAC128 model of Huntington disease.NF-κB Pathways in the Pathogenesis of Multiple Sclerosis and the Therapeutic ImplicationsProgressive multiple sclerosis: from pathogenic mechanisms to treatment.Primary Progressive Multiple Sclerosis: Putting Together the PuzzleDynamic regulation of serum aryl hydrocarbon receptor agonists in MSLaquinimod treatment in the R6/2 mouse model.1,25-Dihydroxyvitamin D3 Protects against Immune-Mediated Killing of Neurons in Culture and in Experimental Autoimmune Encephalomyelitis.MP Resulting in Autophagic Cell Death of Microglia through Zinc Changes against Spinal Cord InjuryLaquinimod dampens hyperactive cytokine production in Huntington's disease patient myeloid cells.Treatment of spontaneous EAE by laquinimod reduces Tfh, B cell aggregates, and disease progression.Laquinimod arrests experimental autoimmune encephalomyelitis by activating the aryl hydrocarbon receptorSynaptopathy connects inflammation and neurodegeneration in multiple sclerosis.Immunosenescence of microglia and macrophages: impact on the ageing central nervous system.Endogenous repair and development inspired therapy of neurodegeneration in progressive multiple sclerosis.Dendritic cells as therapeutic targets in neuroinflammation.The future of multiple sclerosis treatments.Further understanding of the immunopathology of multiple sclerosis: impact on future treatments.Myeloid cells - targets of medication in multiple sclerosis.Clinical quantitative susceptibility mapping (QSM): Biometal imaging and its emerging roles in patient care.Laquinimod prevents cuprizone-induced demyelination independent of Toll-like receptor signalingApolipoprotein E knockout induced inflammatory responses related to microglia in neonatal mice brain via astrocytes.Laquinimod ameliorates excitotoxic damage by regulating glutamate re-uptake.Laquinimod attenuates inflammation by modulating macrophage functions in traumatic brain injury mouse model.Significance and In Vivo Detection of Iron-Laden Microglia in White Matter Multiple Sclerosis Lesions.Laquinimod protects the optic nerve and retina in an experimental autoimmune encephalomyelitis model.Potential immunotherapies for traumatic brain and spinal cord injury.
P2860
Q26752895-8411844E-5E70-40B7-8DFF-29EDC88F08D4Q26772359-32C65871-E2DC-4D26-AEA2-A5E6335D4FF5Q27316866-907D084C-A0EB-4EE4-BA1D-EE73278A53DDQ28078299-F5A0964B-B424-4FB0-9C62-A902BA9D461BQ31139925-21C92C9B-EAE1-4014-A4AE-E01806B916D9Q33365606-C5E8E26E-F279-4558-93FD-4726216E426AQ33808285-698F702C-F77C-42DA-BD3F-7607C5B5525CQ33890346-E02AE1DA-6690-4C69-86EB-83B317C26313Q35872062-80052071-E8CF-455E-9A20-0B141BD26F4FQ36530866-EAEDDCF9-CF84-44ED-8108-C77C335FB599Q37169655-625B262A-A397-4CD9-8D63-E4B6BF00621CQ37274895-6CBD3140-D3AF-42EA-812D-D3AA5A766018Q37346761-7A61F971-CC6A-4E80-A098-A71B3BF9CEF9Q38639337-1D5FCD53-D619-4D96-9BE9-43C806A85DCBQ38749164-EF16540E-C5DA-473D-B1FB-48AA6FAEFD6EQ38765008-309D7DA5-59B4-4CFB-ABEE-97E4979218DDQ38771884-EA744BDD-B215-4456-B343-6E9D3CB7728EQ38808485-B32C56A9-AF4F-4D28-B5F7-1B7E8D1463DBQ38837294-79B88166-B29E-4A4B-A4B7-0ACBF1F13D44Q38924828-6BB4D3BE-A714-49BB-A415-CD5D70B9C229Q39179797-257E0B44-948E-450E-985B-8EB2705E9488Q41845688-EAC42BFF-AF45-4C47-BC07-8CF9B8C3B9E2Q43185058-DB2A1B3A-44BF-4D8E-86E3-DEE5D45A30C5Q47211013-049E356B-DB83-49B1-84EE-9C1A850E428DQ47695368-F32ADD94-0ECE-462F-A1F8-D5DF2C8E6B11Q52668328-B8706A80-7874-4CD2-B129-992A61F5B798Q55428811-F0E41B4D-21F2-4912-863E-17A63C630250Q55505620-CA77F975-4B3E-45DF-ACF4-4CE514F5A2D8
P2860
Laquinimod reduces neuroaxonal injury through inhibiting microglial activation.
description
2014 nî lūn-bûn
@nan
2014 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Laquinimod reduces neuroaxonal injury through inhibiting microglial activation.
@ast
Laquinimod reduces neuroaxonal injury through inhibiting microglial activation.
@en
Laquinimod reduces neuroaxonal injury through inhibiting microglial activation.
@nl
type
label
Laquinimod reduces neuroaxonal injury through inhibiting microglial activation.
@ast
Laquinimod reduces neuroaxonal injury through inhibiting microglial activation.
@en
Laquinimod reduces neuroaxonal injury through inhibiting microglial activation.
@nl
prefLabel
Laquinimod reduces neuroaxonal injury through inhibiting microglial activation.
@ast
Laquinimod reduces neuroaxonal injury through inhibiting microglial activation.
@en
Laquinimod reduces neuroaxonal injury through inhibiting microglial activation.
@nl
P2093
P2860
P356
P1476
Laquinimod reduces neuroaxonal injury through inhibiting microglial activation
@en
P2093
Claudia Silva
Janet Wang
Liat Hayardeny
Michael B Keough
Scott Sloka
Wolfgang Brück
P2860
P304
P356
10.1002/ACN3.67
P577
2014-05-26T00:00:00Z